Medication info

Korea Lidocaine Hydrochloride 2% Injection

Prescription medicationSolutionIntravenous injection
Ingredient · strength
Lidocaine Hydrochloride Hydrate›21.33mg / 1mL
Manufacturer / importer
Daehan Pharmaceutical Co., Ltd.
Appearance
A colorless and transparent solution filled in a colorless and transparent vial.
Packaging
10 vials/box (5mL/vial), 10 vials/box (20mL/vial)
Approval status
Active

MFDS item code 198300121 · Notified 1983.12.16 · Insurance code 645100761,645104361

Summary

Main use
Anesthesia (epidural and nerve block, etc.); treatment of ventricular arrhythmias
Who receives it
Adults
Adult administration
[Anesthesia] Adults 1. Epidural anesthesia (recommended maximum dose: 200㎎ of lidocaine hydrochloride per dose): 200㎎ 2. Conduction anesthesia (recommended maximum dose: 200㎎ of lidocaine hydrochloride per dose): 40-200㎎; 60-120㎎ for nerve block 3. Infiltration anesthesia (recommended maximum dose: 200㎎ of lidocaine hydrochloride per dose): 40-200㎎ 4. Surface anesthesia: Apply or spray an appropriate amount Adjust the dose appropriately according to age, area and site of anesthesia, tissue, symptoms, constitution, and general condition. [Medical use] Adults 1. Single intravenous dose: Slowly inject 50-100㎎ (1-2㎎/㎏) of lidocaine hydrochloride intravenously over 1-2 minutes. If no effect is observed, administer the same dose after 5 minutes. If prolonged effect is desired, the same dose may also be administered additionally at 10-20 minute intervals; however, the recommended maximum dose within 1 hour is 300㎎. 2. Intravenous infusion: If a single intravenous dose is effective and prolonged effect is desired, administer by intravenous infusion under continuous electrocardiographic monitoring. Infuse lidocaine hydrochloride intravenously at a rate of 1-2㎎ per minute. The infusion rate may be increased if necessary, but the maximum rate is 4㎎ per minute.

Ingredients

Manufacturer
Daehan Pharmaceutical Co., Ltd.

Efficacy & effects

Anesthesia (epidural and nerve block, etc.); treatment of ventricular arrhythmias

  • Ventricular arrhythmias
View approved original text

This medication is used in various anesthesia methods such as epidural anesthesia, regional anesthesia, infiltration anesthesia, and surface anesthesia. It is also helpful in treating heart diseases like ventricular arrhythmias. Therefore, it is used to effectively manage anesthesia and cardiac arrhythmias.

How it is given

Adult administration

[Anesthesia] Adults 1. Epidural anesthesia (recommended maximum dose: 200㎎ of lidocaine hydrochloride per dose): 200㎎ 2. Conduction anesthesia (recommended maximum dose: 200㎎ of lidocaine hydrochloride per dose): 40-200㎎; 60-120㎎ for nerve block 3. Infiltration anesthesia (recommended maximum dose: 200㎎ of lidocaine hydrochloride per dose): 40-200㎎ 4. Surface anesthesia: Apply or spray an appropriate amount Adjust the dose appropriately according to age, area and site of anesthesia, tissue, symptoms, constitution, and general condition. [Medical use] Adults 1. Single intravenous dose: Slowly inject 50-100㎎ (1-2㎎/㎏) of lidocaine hydrochloride intravenously over 1-2 minutes. If no effect is observed, administer the same dose after 5 minutes. If prolonged effect is desired, the same dose may also be administered additionally at 10-20 minute intervals; however, the recommended maximum dose within 1 hour is 300㎎. 2. Intravenous infusion: If a single intravenous dose is effective and prolonged effect is desired, administer by intravenous infusion under continuous electrocardiographic monitoring. Infuse lidocaine hydrochloride intravenously at a rate of 1-2㎎ per minute. The infusion rate may be increased if necessary, but the maximum rate is 4㎎ per minute.

Precautions

This drug should not be used in patients with toxic bleeding or in shock, those with inflammation at the injection site or sepsis, and patients allergic to this drug or similar local anesthetics. It should be used cautiously in patients with central nervous system diseases, pregnant women, elderly patients, patients with severe hypertension, and patients with severe spinal deformities. When using this drug, symptoms of shock such as sudden blood pressure drop or facial pallor should be monitored closely, and if abnormal symptoms occur, use should be immediately discontinued, and appropriate treatment should be received. Rarely, severe symptoms of malignant hyperthermia such as high fever, muscle rigidity, arrhythmia, and respiratory distress may occur, so if such symptoms appear, administration should be stopped immediately, and specialized treatment is necessary. The drug may affect the central nervous system and cause tremors, seizures, drowsiness, anxiety, dizziness, and nausea, so any symptoms should be reported immediately. Allergic reactions such as skin rash or swelling may occur, so caution is advised. The risk of side effects may increase when used with vasoconstrictors, so patients with certain conditions or those with hypertension, heart disease, or diabetes should avoid or use vasoconstrictors with caution. Pregnant women should only use this drug when the benefits of treatment outweigh the risks, as its safety has not been fully established. Elderly patients may experience stronger effects or be more prone to side effects, so dosing should be adjusted and their condition closely monitored. This drug should be administered cautiously to patients with impaired liver and kidney function, and due to potential drug interactions that may increase blood concentration, it is important to consult with healthcare professionals about other medications being taken. Long-term use at high concentrations may pose a risk of mutagenesis, so it is advisable to avoid high-dose long-term use whenever possible. When used as a local anesthetic, it is not suitable for surface anesthesia within the airway and should not be used for ophthalmic purposes. This drug should not be used in patients with severe cardiac conduction disorders or hypersensitivity, as it may affect cardiac function, requiring frequent monitoring of electrocardiograms and blood pressure during administration. If adverse reactions occur, notify healthcare professionals immediately to receive appropriate care.

Side effects

shock

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a sealed container, and it is advisable to keep it at room temperature between 1 to 30 degrees Celsius. Storing it this way can help maintain the drug's effectiveness for a longer time.

Appearance and packaging

Appearance

A colorless and transparent solution filled in a colorless and transparent vial.

Package unit

10 vials/box (5mL/vial), 10 vials/box (20mL/vial)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.